Metabonomics techniques and applications to pharmaceutical research & development.
about
Applicability of non-invasively collected matrices for human biomonitoringInvestigating potential mechanisms of obesity by metabolomicsAn effective assessment of simvastatin-induced toxicity with NMR-based metabonomics approachMetabonomic profiles delineate the effect of traditional Chinese medicine sini decoction on myocardial infarction in ratsBioactive Nutrients and Nutrigenomics in Age-Related Diseases.Large-scale neurochemical metabolomics analysis identifies multiple compounds associated with methamphetamine exposureApplication of faecal metabonomics on an experimental model of tubulointerstitial fibrosis by ultra performance liquid chromatography/high-sensitivity mass spectrometry with MS(E) data collection technique.An automated Pearson's correlation change classification (APC3) approach for GC/MS metabonomic data using total ion chromatograms (TICs).Data-handling strategies for metabonomic studies: example of the UHPLC-ESI/ToF urinary signature of tetrahydrocannabinol in humans.Statistical methods for the analysis of high-throughput metabolomics data.Capillary electrophoresis with electrospray ionization mass spectrometric detection for single-cell metabolomics.Pattern recognition analysis of proton nuclear magnetic resonance spectra of brain tissue extracts from rats anesthetized with propofol or isoflurane.Gas chromatography-mass spectrometry-based metabolic profiling of cerebrospinal fluid from epileptic dogs.Whole-cell matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for rapid identification of bacteria cultured in liquid media.Chemometric analysis of biofluids from mice experimentally infected with Schistosoma mansoni.Serum metabonomics study of adenine-induced chronic renal failure in rats by ultra performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.Long term conservation of human metabolic phenotypes and link to heritability.Advances in NMR-based biofluid analysis and metabolite profilingCharacterization of in vitro metabolic profiles of cinitapride obtained with liver microsomes of humans and various mammal species using UHPLC and chemometric methods for data analysis.Classification of osteoarthritis phenotypes by metabolomics analysis.LC-MS based metabolomics identification of novel biomarkers of tobacco smoke-induced chronic bronchitis.Global host metabolic response to Plasmodium vivax infection: a 1H NMR based urinary metabonomic study.Characterization and prediction of the mechanism of action of antibiotics through NMR metabolomics.Radiation Changes the Metabolic Profiling of Melanoma Cell Line B16.Ion chromatography based urine amino Acid profiling applied for diagnosis of gastric cancer.Profiling the metabolome changes caused by cranberry procyanidins in plasma of female rats using (1) H NMR and UHPLC-Q-Orbitrap-HRMS global metabolomics approaches.1H NMR metabonomics approach to the disease continuum of diabetic complications and premature deathIsotope enhanced approaches in metabolomics.A Systematic, Integrated Study on the Neuroprotective Effects of Hydroxysafflor Yellow A Revealed by (1)H NMR-Based Metabonomics and the NF-κB Pathway.Factor analysis reveals differences in brain metabolism in macaques with SIV/AIDS and those with SIV-induced encephalitis.Use of the local false discovery rate for identification of metabolic biomarkers in rat urine following Genkwa Flos-induced hepatotoxicityPotential of urinary biomarkers in early bladder cancer diagnosis.Application of metabolomics to cardiovascular biomarker and pathway discovery.15N-cholamine--a smart isotope tag for combining NMR- and MS-based metabolite profilingIndividual variation in macronutrient regulation measured by proton magnetic resonance spectroscopy of human plasma.Metabolomics-based methods for early disease diagnosticsPostgenomics diagnostics: metabolomics approaches to human blood profiling.RAMSY: ratio analysis of mass spectrometry to improve compound identification.Lipid profiles of canine invasive transitional cell carcinoma of the urinary bladder and adjacent normal tissue by desorption electrospray ionization imaging mass spectrometry.Nuclear magnetic resonance spectroscopy-based metabolomics of the fatty pancreas: implicating fat in pancreatic pathology.
P2860
Q24653435-301A713A-0C7E-4D87-942A-D6933EF25174Q26865774-29737D65-7424-461D-8D97-682CB3884E8AQ28477228-7AF6F118-5FE9-47A4-8551-EE469789D9A1Q28482167-0DF6C46C-66AB-4B8F-B162-9FA7ACD1F097Q30239072-1C0944E9-359B-4C95-B706-9EC852EA8E91Q30538147-7DCB3620-D063-49E1-8660-194F47B0BCBFQ30571181-5D21CC7D-9FD1-47F8-97EE-26DFE1FE9094Q30607142-D3BE5019-7CDD-4F40-88D1-FCDBD556FD0DQ30658279-1FD33904-3880-4393-A521-3981DF3BB716Q30790493-0E364207-DE05-4921-AA89-2455CFD1337DQ33606017-65C2F477-4D1D-46A1-AC6E-7C37A14925D3Q33612276-3FA0F870-3D29-42B0-B4DA-343D834FA7BEQ33780386-8170DED7-B34B-46E7-8C88-84A1AA22537EQ33799400-92E739CE-0F35-4FFD-9CDC-33F7E674B114Q34022236-E0DB0D85-B146-4542-8994-C0092E92F7BBQ34088508-08CC41DD-913C-4B70-8043-E5C449AF4630Q34091261-E4A7B108-9BD6-49C0-8C20-FBCDF910D9E7Q34109340-5CF4E135-DACB-4D0A-B65F-904EB19CB0D3Q34169406-C61B14F3-A38F-44BE-ACC6-029A110E8FE1Q34573194-C7D9480A-8554-4189-9683-10347B7678CDQ35781857-E049725C-4FBA-46F6-934E-336A64666A8BQ35818517-B8F6CC57-2EEA-4AFC-BFDA-586A336E2610Q36012460-DFB377BB-07DD-4F33-941C-CE66D98F2C1DQ36134296-A74E5D66-C860-4927-B93D-79E3441D4D11Q36135050-B509AB7F-CCC4-4CD5-B64E-9D79BE6DDB60Q36470225-D1E68FC3-CDE1-4215-83F8-A8ED4C546125Q36496258-FED5E62C-7238-4F25-83B1-415FC1818465Q36581517-06EB674A-6882-45D1-A87F-1ADDBCB13F15Q36845107-39AC1FB3-A754-4639-A923-41E650090B61Q36924984-8FB84954-5E15-4BB2-900A-223975FD8F72Q36976535-8566B227-6FC9-458A-8E94-786FCCC555B3Q37008860-D05AC407-4743-4A86-A169-63A888D8912CQ37206431-9DB58946-7ED9-495B-85C6-D55F601434BEQ37243168-C3D5969A-4C3E-4489-A67E-2A9E998FDD4EQ37264286-D4D940D9-D6B3-4540-9418-DCEEB0BFA2E2Q37266489-5E881B18-F94E-4E4C-88A7-7AC8D948541DQ37272725-95A720AE-4948-4E26-A6C4-34A2B22A4F6BQ37402081-4462AEA1-18F9-415D-814E-62B04E4A3137Q37438601-E6D84768-ECAE-4A7D-A3C4-79B3CA9DEC11Q37466922-C90A9AA5-4A9B-4903-BD17-9B09CF20BFCD
P2860
Metabonomics techniques and applications to pharmaceutical research & development.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Metabonomics techniques and applications to pharmaceutical research & development.
@ast
Metabonomics techniques and applications to pharmaceutical research & development.
@en
type
label
Metabonomics techniques and applications to pharmaceutical research & development.
@ast
Metabonomics techniques and applications to pharmaceutical research & development.
@en
prefLabel
Metabonomics techniques and applications to pharmaceutical research & development.
@ast
Metabonomics techniques and applications to pharmaceutical research & development.
@en
P1476
Metabonomics techniques and applications to pharmaceutical research & development.
@en
P2093
Elaine Holmes
John C Lindon
P304
P356
10.1007/S11095-006-0025-Z
P577
2006-05-25T00:00:00Z